AML development with high incidence and rapid onsetEnhancement of primitive hematopoiesis through alteration of transcription factors (pu.1, gata1, scl, lmo2, p27kip and p21cip1)Activation of major cancer signaling pathways. The gene discussed is CDKN1A; the disease is cancer.